全文获取类型
收费全文 | 20288篇 |
免费 | 3191篇 |
国内免费 | 1004篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 247篇 |
妇产科学 | 306篇 |
基础医学 | 2103篇 |
口腔科学 | 330篇 |
临床医学 | 2584篇 |
内科学 | 2723篇 |
皮肤病学 | 147篇 |
神经病学 | 2205篇 |
特种医学 | 473篇 |
外国民族医学 | 1篇 |
外科学 | 1797篇 |
综合类 | 2946篇 |
现状与发展 | 4篇 |
预防医学 | 2578篇 |
眼科学 | 331篇 |
药学 | 2076篇 |
19篇 | |
中国医学 | 1983篇 |
肿瘤学 | 1534篇 |
出版年
2024年 | 93篇 |
2023年 | 854篇 |
2022年 | 1505篇 |
2021年 | 2138篇 |
2020年 | 1888篇 |
2019年 | 1381篇 |
2018年 | 1078篇 |
2017年 | 1075篇 |
2016年 | 1047篇 |
2015年 | 1168篇 |
2014年 | 2096篇 |
2013年 | 1749篇 |
2012年 | 1425篇 |
2011年 | 1313篇 |
2010年 | 914篇 |
2009年 | 771篇 |
2008年 | 786篇 |
2007年 | 656篇 |
2006年 | 526篇 |
2005年 | 417篇 |
2004年 | 313篇 |
2003年 | 243篇 |
2002年 | 161篇 |
2001年 | 119篇 |
2000年 | 121篇 |
1999年 | 103篇 |
1998年 | 86篇 |
1997年 | 89篇 |
1996年 | 56篇 |
1995年 | 69篇 |
1994年 | 53篇 |
1993年 | 39篇 |
1992年 | 26篇 |
1991年 | 22篇 |
1990年 | 17篇 |
1989年 | 17篇 |
1988年 | 12篇 |
1987年 | 13篇 |
1986年 | 13篇 |
1985年 | 8篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1980年 | 4篇 |
1979年 | 1篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Ahmad Adebayo Irekeola Engku Nur Syafirah E.A.R. Yusuf Wada Rohimah Mohamud Norhafiza Mat Lazim Chan Yean Yean Rafidah Hanim Shueb 《Indian journal of medical microbiology》2022,40(3):420-426
BackgroundEpstein-Barr virus (EBV) is a member of the herpesvirus family that is known to ubiquitously infect people worldwide. However, the actual prevalence of EBV infection in diseased patients in Nigeria, remains unknown. This study was thus conducted to ascertain the true prevalence.MethodsA systematic review and meta-analysis of published data was conducted according to the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). Electronic databases including PubMed, Scopus, ScienceDirect, and Google Scholar were searched for studies reporting the occurrence of EBV infection among patients with established diseases. Studies were included if they assessed EBV infection in diseased patients in Nigeria. Data were extracted and subsequently analysed using R software. Funnel plot and Egger's regression test was used to assess publication bias, while JBI prevalence tool was used to assess study quality.ResultsA total of 13 studies covering 228 cases of EBV infection among 1157 diseased patients were included. Summary estimates were computed using random-effects model. The pooled prevalence of EBV infection was 20.3% (95% CI: 10.8–34.9, I2 ?= ?92.26, p ?< ?0.001). When stratified according to the type of disease, higher estimates were obtained for patients suffering from Kaposi's sarcoma (98.7%, 95% CI: 82.2–99.9) and Nasopharyngeal malignancy (85.7%, 95% CI: 70.0–93.9). A prevalence of 13.4% (95% CI: 6.0–27.4) and 12.2% (95% CI: 4.8–27.8) was derived for the most reported patient populations, lymphoma and HIV, respectively.ConclusionThis first meta-analysis on the prevalence of EBV among Nigerian patients suffering from various diseases reveals a prevalence that emphasises the need to routinely monitor EBV infection in all EBV-associated diseases in Nigeria. 相似文献
3.
4.
《结合医学学报(英文版)》2022,20(6):497-513
BackgroundFiliform needle acupuncture (FNA), the most classical and widely applied acupuncture method based on traditional Chinese medicine theory, has shown a promising effect in the treatment of allergic rhinitis (AR).ObjectiveTo evaluate the efficacy, safety, cost-effectiveness, and patient preference of FNA in the treatment of AR by comparing FNA with sham acupuncture, no treatment, and conventional medication.Search strategyEight electronic databases were systematically searched from inception to October 14, 2021. Additional studies were acquired from clinical trial registration platforms and reference lists.Inclusion criteriaRandomized controlled trials were included if they compared FNA with either sham acupuncture, no treatment or conventional medication for AR.Data extraction and analysisTwo researchers extracted data independently of each other using a predesigned data acquisition form, and results were cross-checked after completion. The primary outcome was symptom score (Total Nasal Symptom Score or Visual Analogue Scale), and the secondary outcomes were the AR control questionnaire, quality of life (QoL) score (Different versions of Rhinoconjunctivitis Quality of Life Questionnaire), medication score (use of rescue medication), mental health score, total IgE, adverse event rate, clinical economic indicators, and patient satisfaction score. Standardized mean difference (SMD) or mean difference (MD) with 95% confidence interval was used to calculate the effect size for continuous data, while risk ratio with 95% CI was used for dichotomous data.ResultsThirty studies were included in this review. Compared with sham acupuncture, FNA significantly reduced the symptom score (SMD: ?0.29 [?0.43, ?0.15]), AR’s impact on QoL (SMD: ?0.23 [?0.37, ?0.08]) and medication score (SMD: ?0.3 [?0.49, ?0.11]). Compared with no treatment, FNA dramatically reduced the symptom score (SMD: ?0.8 [?1.2, ?0.39]) and AR’s impact on QoL (SMD: ?0.82 [?1.13, ?0.52]). There were no increased rates of adverse events with FNA compared to sham acupuncture and no treatment. FNA increased patient satisfaction and may be cost-effective. Most pieces of evidence from the above two comparisons were of high confidence. Moreover, FNA significantly outperformed conventional medication in reducing the symptom score (SMD: ?0.48 [?0.85, ?0.1]) and displayed a lower rate of adverse events, but the quality of evidence was very low.ConclusionFNA is an effective and safe intervention for AR and can help with symptom relief, QoL improvement, reducing medication usage, and increasing patient satisfaction. Further studies are needed to verify its cost-effectiveness and superiority over conventional medication and the best therapeutic strategies. 相似文献
5.
6.
7.
8.
9.
目的 通过网络药理学及分子对接技术探寻复方一枝蒿颗粒治疗新型冠状病毒肺炎的作用机制。方法 应用TCMSP数据库、BATMAN-TCM数据库及文献收集复方一枝蒿颗粒活性成分及潜在靶点。通过TTD、GeneCards和OMMI数据库检索新型冠状病毒肺炎相关的靶点。将复方一枝蒿颗粒药物靶点和新型冠状病毒肺炎相关基因取交集,使用String数据库构建靶蛋白相互作用(PPI)网络。通过Cytoscape构建“药物–活性成分–靶点基因–疾病”网络。对交集靶点进行GO功能、KEGG通路富集分析。利用Autodock_vina软件对活性成分和靶点进行分子对接。结果 共筛选92个活性成分,1 627个靶点,新型冠状病毒肺炎疾病靶点464个,两者取交集筛选出87个潜在靶点。GO功能富集得到2 040个条目(P<0.05),与病毒过程、参与共生相互作用的生物过程、活性氧代谢过程的调节、与宿主相互作用的生物过程、病毒生命周期、炎症反应的调节等生物学过程有关。KEGG通路分析共得到150条通路,与新冠肺炎密切相关的有人巨细胞病毒感染、结核、COVID-19、IL-17信号通路等。分子对接结果证实,筛选的靶点受体蛋白与活性成分可以较好地结合。结论 复方一枝蒿颗粒可通过多组分、多靶点和多途径的方式对新型冠状病毒肺炎产生治疗作用。 相似文献
10.